Position in ABVX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$706,278
+$38,178 QoQ
Shares Held
5,300
-11.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
#184
of 302 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Global Investment Management, LLC holds $3,747,880 across 6 Biotechnology names. ABVX ranks #4 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,500 | $805,425 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,500 | $752,575 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
4,000 | $749,120 | |
| 4 | ABVX |
Abivax S.A.
This page
|
5,300 | $706,278 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
5,900 | $559,025 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
10,321 | $175,457 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $706,278 | 5,300 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $668,100 | 6,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $294,253 | 2,182 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||